Skip to main content
SpringerLink
Log in

Synergistic Activity for Natural and Synthetic Inhibitors of Angiogenesis Induced by Murine Sarcoma L-1 and Human Kidney Cancer Cells

  • Chapter
  • First Online:
Clinical Research and Practice

Part of the book series: Advances in Experimental Medicine and Biology ((NR,volume 1020))

Abstract

Tumor angiogenesis is an important link in the process of tumor growth and metastasis. A number of substances with an anti-angiogenic activity has been described, but their efficiency remains low. Many researchers believe that a better therapeutic effect could be achieved using a cocktail of several anti-angiogenic agents, having different points of action. A lot of synthetic and natural products of plant and animal origin have anti-tumor and anti-angiogenic properties. The aim of the present study was to evaluate the effect of some combinations of angiogenesis inhibitors on the growth and neovascularization of murine sarcoma L-1 , and on angiogenesis induced in the mouse skin by grafting of human renal cancer. The influence of theobromine, sulindac and its metabolite sulindac sulfone, chlorogenic acid, and shark liver oil on the afferent and efferent angiogenesis pathways was tested. Individually, all of these substances suppressed tumor growth and angiogenesis. Synergy was found for a combination of theobromine, sulindac, and chlorogenic acid (L-1 sarcoma tumor growth), and for theobromine with sulindac sulfone or with shark liver oil, which were given to the mice grafted with human renal cancer cells (angiogenesis). No synergistic effects were shown after preincubation with tumor cells and inhibitors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alessi P, Leali D, Camozzi M, Cantelmo A, Albini A, Presta M (2009) Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel anti-angiogenic FGF2-antagonists. Eur Cytokine Netw 20:225–234

    CAS  PubMed  Google Scholar 

  • Bałan BJ, Skopińska-Różewska E, Barcz E, Sokolnicka I, Gawrychowski K, Strzelecka H (1999) The effect of selected phenolic acids in angiogenic activity of ovarian cancer cells. Onkol Pol 4:203–208. (Article in Polish)

    Google Scholar 

  • Barcz E, Sommer E, Sokolnicka I, Gawrychowski K, Roszkowska-Purska K, Janik P, Skopińska-Różewska E (1998) The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancers cells. Oncol Rep 5:517–520

    CAS  PubMed  Google Scholar 

  • Barcz E, Sommer E, Janik P, Marianowski L, Skopińska-Różewska E (2000) Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells. Oncol Rep 7:1285–1291

    CAS  PubMed  Google Scholar 

  • Beaumont JL, Salsman JM, Diaz J, Deen KC, McCann L, Powles T, Hackshaw MD, Motzer RJ, Cella D (2016) Quality-adjusted time without symptoms or toxicity analysis of pzopanib vesrsus sunitynib in patients with renal cell carcinoma. Cancer 122:1108–1115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Boissier E, Mir O, Hollebecque A, Izzedine H, Ederhy S, Gazzah A, Bahleda R, Missard C, Macquin-Mavier I, Tournigand C, Spano JP, Soria JC, Rousseau B (2016) Predictive factors of renal toxicities related to anti-VEGFR multikinase inhibitors in phase 1 trials. Invest New Drugs. Oct 25 (Epub ahead of print)

    Google Scholar 

  • Brohult A, Brohult J, Brohult S (1970) Biochemical effects of alkoxyglicerols and their use in cancer therapy. Acta Chem Scand 24:730–735

    Article  CAS  PubMed  Google Scholar 

  • Cassinelli G, Lanzi C, Tortoreto M, Cominetti D, Petrangolini G, Favini E, Zaffaroni N, Pisano C, Penco S, Vlodavsky I, Zunino F (2013) Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangigenic agents in the treatment of human pediatric sarcoma model. Biochem Pharmacol 15:1424–1432

    Article  Google Scholar 

  • Chen HX, Cleck JN (2009) Adverse effects of anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol 6:465–477

    Article  CAS  PubMed  Google Scholar 

  • Chou T-C (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621–681

    Article  CAS  PubMed  Google Scholar 

  • Choueiri TK, Escudier B, Powels T, Tannir NM, Mainwaring PN, Rini BI, Hammers HJ, Donskov F, Roth BJ, Peltola K, Lee JL, Heng DY, Schmidinger M, Agarval N, Sternberg CN, McDermott DF, Aftap DT, Hessel C, Scheffold C, Schwab G, Hutson TE, Pal S, Motzer RJ, METEOR investigators (2016) Cabozanitib versus everolimus in advanced renal cell carcinoma (METEOR): final results from the randomised, open-label, phase 3 trial. Lancet Oncol 17:919–927

    Article  Google Scholar 

  • Chougule M, Patel AR, Sachdeva P, Jackson T, Singh M (2011) Anticancer activity of noscapine, an opioid alkaloid in combination with cisplatine in human non-small cell lung cancer. Lung Cancer 73:271–282

    Article  Google Scholar 

  • Cook KM, Figg WD (2010) Angiogenesis inhibitors – current strategies and future prospects. CA Cancer J Clin 60:222–243

    Article  PubMed  PubMed Central  Google Scholar 

  • D’Angelo G, Lee H, Weiner RI (1997) cAMP-dependent protease inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking raf activation. J Cell Biochem 67:353–366

    Article  PubMed  Google Scholar 

  • Ebrahim HY, El Sayed KA (2016) Discovery of novel anti-angiogenic marine natural product scaffolds. Mar Drugs 14(3):pii:E57; doi:10.3390/md14030057

  • Elwich-Flis S, Sołtysiak-Pawluczuk D, Spławinski J (2003) Anti-angiogenic and apoptotic effects of metabolites of sulindac on chick embryo chorioallantoic membrane. Hybrid Hybridomics 22:55–60

    Article  CAS  PubMed  Google Scholar 

  • Flis S, Sołtysiak-Pawluczuk D, Jędrych A, Jastrzębski Z, Remiszewska M, Spławinski J (2006) Anti-angiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest. Anticancer Res 26:3033–3042

    CAS  PubMed  Google Scholar 

  • Gacche RN, Meshram RJ (2014) Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy. Biochim Biophys Acta 1846:161–179

    CAS  PubMed  Google Scholar 

  • Gibka J, Wasiutyński A, Skopińska-Różewska E, Siwicki AK, Chorostowska Wynimko J, Sommer E, Mazurkiewicz M, Gliński M, Skurzak H, Wojcik R, Jung L (2010) The effect of undecanones and their derivatives on tumor angiogenesis and VEGF content. Pol J Vet Sci 13:105–115

    CAS  PubMed  Google Scholar 

  • Gil M, Skopińska-Różewska E, Radomska D, Demkow U, Skurzak H, Rochowska M, Beuth J, Roszkowski K (1993) Effect of purinergic receptor antagonists suramin and theobromine on tumor-induced angiogenesis in Balb/c mice. Folia Biol 39:63–68

    CAS  Google Scholar 

  • Haanen C (2001) Sulindac and its derivatives: a novel class of anticancer agents. Curr Opin Investig Drugs 2:677–683

    CAS  PubMed  Google Scholar 

  • Heider U, von Metzler I, Kaiser M, Rosche M, Sterz J, Rotzler S, Rademacher J, Jacob C, Fleissner C, Kuckelkorn U, Kloetzel PM, Sezer O (2008) Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma. Eur J Hematol 80:133–142

    Article  CAS  Google Scholar 

  • Jackson JK, Burt HM, Octaba AM, Hunter W, Scheid MP, Mouchajir F, Lauener RW, Shen Y, Salari H, Duronio V (1998) The antineoplastic ether lipid, s-phosphonate selectively induces apoptosis in human leukemic cells and exhibits anti-angiogenic and apoptotic activity on the chorioallantoic membrane of the chick embryo. Cancer Chemother Pharmacol 41:326–332

    Article  CAS  PubMed  Google Scholar 

  • Jakubowska-Mućka A, Sienko J, Świtaj T, Gołąb J, Lasek W (2012) Antitumor effect of sulindac in ovarian cell cultures. Ginekol Pol 82:195–199 (Article in Polish)

    Google Scholar 

  • Janik P (1976) Lung colony assay in normal, irradiated and tumor bearing mice. Neoplasma 23:495–497

    CAS  PubMed  Google Scholar 

  • Jin UH, Lee JY, Kang SK, Park WH, Kim JG, Moon SK, Kim CH (2005) A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus. Life Sci 77(22):2760–2769

    Article  CAS  PubMed  Google Scholar 

  • Kamei H, Koide T, Kojimam T, Hasegawa M, Terabe K, Umeda T, Hashimoto Y (1996) Flavonoid-mediated tumor growth suppresion demonstrated by in vivo study. Cancer Biother Radiopharm 11:193–196

    Article  CAS  PubMed  Google Scholar 

  • Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT (2005) The antitumor activities of flavonoids. In Vivo 19:895–899

    PubMed  Google Scholar 

  • Kim C, Yu HG, Sohn J (2010) The anti-angiogenic effect of chlorogenic acid on choroidal neovascularization. Korean J Ophthalmol 24:163–168

    Article  PubMed  PubMed Central  Google Scholar 

  • Leitman DC, Fiscus RR, Murad F (1986) Forskolin, phosphodiesterase inhibitors, and cyclic AMP analogs inhibit proliferation of culured bovine aortic endothelial cells. J Cell Physiol 127:237–243

    Article  CAS  PubMed  Google Scholar 

  • Li H, Zhu X, Zhang Y, Xiang J, Chen H (2009) Arsenic trioxide exerts synergistic effect with cisplatin on non-small cell lung cancer cells via apoptosis induction. J Exp Clin Cancer Res 28:110. doi:10.1186/1756-9966-28-1101Ll

    Article  PubMed  PubMed Central  Google Scholar 

  • Li N, Xi Y, Tinsley HN, Gurpinar E, Gary BD, Zhu B, Li Y, Chen X, Keeton AB, Abadi AH, Moyer MP, Grizzie WE, Chang WC, Clapper ML, Piaza GA (2013) Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/beta catenin signaling. Mol Cancer Ther 9:1848–1859

    Article  Google Scholar 

  • Li Q, Wang X, Dai T, Liu C, Li T, McClements DJ, Liu J (2016) Proanthocyanidins, isolated from Choerospondias axillaris fruit peels, exhibit potent antioxidant activities in vitro and a novel anti-angiogenic property in vitro and in vivo. J Agric Food Chem 64:3546–3556

    Article  CAS  PubMed  Google Scholar 

  • Liou JY, Wu CC, Chen BR, Yen LB, Wu KK (2008) Nonsteroidal anti-inflammatory drugs induced endothelial apoptosis by perturbing peroxisome proliferator-activated receptor transcriptional pathway. Mol Pharmacol 74:1399–1406

    Article  CAS  PubMed  Google Scholar 

  • Moodie SA, Martin W (1991) Effects of cyclic nucleotides and phorbol myristate acetate on proliferation of pig aortic endothelial cells. Br J Pharmacol 102:101–106

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nartowska J, Sommer A, Siwicki AK, Bany J, Skurzak H, Augustynowicz J, Skopińska- Różewska E (2005) The anti-angiogenic and immunotropic properties of convallamaroside, a steroidal saponin isolated from rhizomes and roots of Convallaria majalis L. Pol J Environ Stud 14:296–299

    Google Scholar 

  • Park JJ, Hwang SJ, Park JH, Lee HJ (2015) Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1 alpha/AKT pathway. Cell Oncol 38:111–118

    Article  CAS  Google Scholar 

  • Pedrono F, Martin B, Leduc C, Le Lan J, Saiag B, Legrand P, Moulinoux JP, Legrand AB (2004) Natural alkylglycerols restrain growth and metastasis of grafted tumors in mice. Nutr Cancer 48:64–69

    Article  CAS  PubMed  Google Scholar 

  • Petrelli A, Giordano S (2008) From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage. Curr Med Chem 15:422–432

    Article  CAS  PubMed  Google Scholar 

  • Piazza GA, Thompson WJ, Pamukcu R, Alila HW, Whitehead CM, Liu L, Fetter JR, Gresh WE Jr, Klein-Szanto AJ, Farnell DR, Eto I, Grubbs CJ (2001) Exisulind, a novel proapoptic drug, inhibits rat urinary bladder tumorigenesis. Cancer Res 61:3961–3968

    CAS  PubMed  Google Scholar 

  • Pietrosiuk A, Furmanowa M, Skopińska-Rożewska E, Sommer E, Skurzak H, Bany J (2004) The effect of acetylshikonin isolated from Lithospermum canescens roots on tumor-induced cutaneous angiogenesis. Acta Pol Pharm 61:379–382

    CAS  PubMed  Google Scholar 

  • Pozdeyev N, Berlinberg A, Zhou Q, Wuensch K, Shibata H, Wood WM, Haugen BR (2015) Targeting the NF-KB pathway as a combination therapy for advanced thyroid cancer. PLoS One 10(8):e0134901. doi:10.1371/journal.pone.013

    Article  PubMed  PubMed Central  Google Scholar 

  • Rapisarda A, Melillo G (2012) Role of the VEGF/VEGFR axis in cancer biology and therapy. Adv Cancer Res 114:237–267

    Article  CAS  PubMed  Google Scholar 

  • Ribatti D (2016) Tumor refractoriness to anti-VEGF therapy. Oncotarget 7(29):46668–46677

    Article  PubMed  PubMed Central  Google Scholar 

  • Rini BI, McDermott DF, Hammers H, Bro W, Bukowski RM, Faba B, Faba J, Figlin RA, Hutson T, Jonasch E, Joseph RW, Leibovich BC, Olencki T, Pantuck AJ, Quinn DI, Seery V, Voss MH, Vood CG, Atkins MB (2016) Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma. J Immunother Cancer 4:81; e-Collection 2016

    Google Scholar 

  • Rogala E, Skopińska-Różewska E, Sommer E, Sokolnicka I, Rudziński P, Caban P, Sawicka E, Pastewka K (2000) The effect of sulindac on angiogenic activity of human lung and kidney tumor cells. Onkol Pol 3:77–83 (Article in Polish)

    Google Scholar 

  • Saaristo A, Karpanen T, Alitalo K (2000) Mechanism of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 19:6122–6129

    Article  CAS  PubMed  Google Scholar 

  • Sagar SM, Yance D, Wong RK (2006a) Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer; part 1. Curr Oncol 13:14–26

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sagar SM, Yance D, Wong RK (2006b) Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer; part 2. Curr Oncol 13:99–107

    CAS  PubMed  PubMed Central  Google Scholar 

  • Santini D, Caragalia M, Vincenzi B, Holen I, Scarpa S, Budillon A, Tonini G (2006) Mechanism of disease: preclinical reports of antineoplastic synergistic action of bisphosphonates. Nat Clin Pract Oncol 3:325–338

    Article  CAS  PubMed  Google Scholar 

  • Shi L, Zhou J, Wu J, Shen Y, Li X (2016) Anti-angiogenic therapy: strategies to develop potent VEGFR-2 tyrosine kinase inhibitors and future prospect. Curr Med Chem 23:1000–1040

    Article  CAS  PubMed  Google Scholar 

  • Shin JY, Sohn J, Park KH (2013) Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model. J Korean Med Sci 28:608–613

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Skopińska-Różewska E, Piazza GA, Sommer E, Pamukcu R, Barcz E, Filewska M, Kupis W, Caban R, Rudziński P, Bogdan J, Mlekodaj S, Sikorska E (1998a) Inhibition of angiogenesis by sulindac and its sulfone metabolite (FGN-1): a potential mechanism of their antineoplastic properties. Int J Tissue React 20:85–89

    PubMed  Google Scholar 

  • Skopińska-Różewska E, Janik P, Przybyszewska M, Sommer E, Białas-Chromiec B (1998b) Inhibitory effect of theobromine on induction of angiogenesis and VEGF mRNA expression in v-raf transfectants of human urethelial cells HCV-29. Int J Mol Med 2:649–652

    PubMed  Google Scholar 

  • Skopińska-Różewska E, Krotkiewski M, Sommer E, Rogala E, Filewska M, Białas-Chromiec B, Pastewka K, Skurzak H (1999) Inhibitory effect of shark liver oil on cutaneous angiogenesis induced in Balb/c mice by syngeneic sarcoma L-1, human urinary bladder and human kidney tumor cells. Oncol Rep 6:1341–1344

    PubMed  Google Scholar 

  • Skopinska-Różewska E, Białas-Chromiec B, Rogala E, Filewska M, Skurzak H (2001) Inhibitory effect of sulindac on L1 sarcoma growth in mice. Terapia 9(3/2):25–27 (Article in Polish)

    Google Scholar 

  • Skopińska-Różewska E, Chorostowska-Wynimko J, Krotkiewski M, Rogala E, Demkow U, Skurzak H (2003) Inhibitory effect of Greenland shark liver oil combined with squalen and arctic birch ashes on angiogenesis and L-1 sarcoma growth in Balb/c mice. Pol J Vet Sci 6:54–56

    PubMed  Google Scholar 

  • Skopińska-Różewska E, Skurzak H, Wasiutyński A, Jung L, Siwicki AK, Bałan BJ, Sommer E, Mazurkiewicz M, Skorupski M, Prątnicki A, Sokolnicka I, Skopiński P (2007) Sarcoma L-1 in mice as a model for the study of experimental angiogenesis. Cent Eur J Immunol 32:77–83

    Google Scholar 

  • Skopińska-Różewska E, Wasiutyński A, Skopiński P, Siwicka D, Zdanowski R, Bodera P (2011) In vivo effect of two complex herbal remedies Echinasal and Bioaron C on antibody production and immunological angiogenesis in mice. Cent Eur J Immunol 3:139–144

    Google Scholar 

  • Skopiński P, Szaflik J, Duda-Król B, Nartowska J, Sommer E, Chorostowska-Wynimko J, Demkow U, Skopińska-Różewska E (2004) Suppresion of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal orgin and sulindac sulfone. Int J Mol Med 14:707–711

    PubMed  Google Scholar 

  • Skopiński P, Skopińska-Różewska E, Sommer E, Siwicki AK, Wasiutyński A (2005) The effect of some diet-derived angiogenesis inhibitors and sulindac sulfone on the ability of VEGF, bFGF and IL-18 to induce cutaneous neo-vascular response in mice. Pol J Environ Stud 14(Suppl II):325–329

    Google Scholar 

  • Skopiński P, Zdanowski R, Bałan BJ, Siwicki AK, Kocik J, Lewicki S, Suska M, Pastewka K, Skopińska-Różewska E, Demkow U (2013a) Aloe arborescens And American cranberry (Vaccinium macrocarpon) extracts inhibit tumor-induced cutaneous angiogenesis in mice. Cent Eur J Immunol 38:480–485

    Article  Google Scholar 

  • Skopiński P, Bałan BJ, Kocik J, Zdanowski R, Lewicki S, Niemcewicz M, Gawrychowski K, Skopińska-Rozewska E, Stankiewicz W (2013b) Inhibitory effect of herbal remedy PERVIVO and anti-inflammatory drug sulindac on L-1 sarcoma tumor growth and tumor angiogenesis in Balb/c mice. Mediat Inflamm 2013:289789. doi:10.1155/2013/289789

    Google Scholar 

  • Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H (1999) Synergistic effects of epigallocatechin gallate with epicatechin, sulindac, tamoxifen on cancer preventive activity in the human lung cancer cell line PC-9. Cancer Res 59:44–47

    CAS  PubMed  Google Scholar 

  • Sugimoto N, Miwa S, Hitomi Y, Nakamura H, Tsuchija H, Yachie A (2014) Theobromine, the primary methylxantine found in Theobroma cacao, prevents malignant glioblastoma proliferation by negatively regulating phosphodiesterase-4, extracellular signal-regulated kinase, act/mammalian target of rapamycin kinase, and nuclear factor-kappa B. Nutr Cancer 66:419–423

    Article  CAS  PubMed  Google Scholar 

  • Tonra JR, Hicklin DJ (2007) Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy. Immunol Investig 36:3–23

    Article  CAS  Google Scholar 

  • Tran TA, Leong HS, Pavia-Jimenez A, Fedyshyn S, Yang J, Kucejowa B, Sivanand S, Spence P, Xie XJ, Pena-Llopis S, Power N, Brugarolas J (2016) Fibroblast growth factor receptor- depended and -independend paracrine signaling by sunitinib-resistant renal cell carcinoma. Mol Cell Biol 36:1836–1855

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Verhoef C, de Wilt JH, Verheul HM (2006) Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology. Curr Pharm Des 12:2623–2630

    Article  CAS  PubMed  Google Scholar 

  • Vogler WR, Liu J, Volpert O, Ades EW, Bouck N (1998) The anticancer drug edelfosine is a potent inhibitor of neovascularisation in vivo. Cancer Investig 16:549–553

    Article  CAS  Google Scholar 

  • Wang LH, Li Y, Yang SN, Wang FY, Hou Y, Cui W, Chen K, Cao Q, Wang S, Zhang TY, Wang ZZ, Xiao W, Yang JY, Wu CF (2014) Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer trough suppressing NF-KB and MAPK/HO-1 signaling. Br J Cancer 110:341–352

    Article  CAS  PubMed  Google Scholar 

  • Whitt DJ, Li N, Tinsley HN, Chen X, Zhang W, Li Y, Gary BD, Keeton AB, Abadi AH, Grizzle WE, Piazza GA (2012) A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and beta catenin transcriptional activity. Cancer Prev Res 5:822–833

    Article  CAS  Google Scholar 

  • Yang J, Jiang M, Zhen YS (2003) Novobiocine inhibits and shows synergistic effect with wincristine. Xao Xue Bao 38:731–734 (Article in Chinese)

    Google Scholar 

  • Yeong LT, Abdul Hamid R, Saiful Yazan L, Khaza’ai H, Awang Hamisin DE (2014) Synergistic action of compounds isolated from the hexane extract of Ardisia crispa root against tumor-promoting effect, in vitro. Nat Prod Res 28:2026–2030

    Article  CAS  PubMed  Google Scholar 

  • Zdanowski R, Skopińska-Różewska E, Wasiutyński A, Skopiński P, Siwicki AK, Sobiczewska E, Lewicki S, Buchwald W, Kocik J, Stankiewicz W (2012) The effect of Rhodiola kirilowii extracts on tumor-induced angiogenesis in mice. Cent Eur J Immunol 37:131

    Google Scholar 

Download references

Conflicts of Interest

The authors declare no conflicts of interest in relation to this article.

Author information

Authors and Affiliations

  1. Department of Immunology, Biochemistry and Nutrition, Warsaw Medical University, 3 Oczki Street, 02-007, Warsaw, Poland

    Barbara J. Bałan

  2. Department of Microbiology and Clinical Immunology, University of Warmia and Mazury, 13 Oczapowskiego Street, 10-957, Olsztyn, Poland

    Andrzej K. Siwicki

  3. Department of Urology, Dr. Tytus Chałubiński Hospital, 4 Lekarska Street, 26-600, Radom, Poland

    Krzysztof Pastewka

  4. Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Warsaw Medical University, Warsaw, Poland

    Urszula Demkow

  5. Department of Histology and Embryology, Center for Biostructure Research, Warsaw Medical University, 5 Chałubińskiego Street, 02-004, Warsaw, Poland

    Piotr Skopiński

  6. Department of Pathomorphology, Center for Biostructure Research, Warsaw Medical University, 5 Chałubińskiego Street, 02-004, Warsaw, Poland

    Ewa Skopińska-Różewska

  7. Department of Immunology, Biochemistry and Nutrition, Warsaw Medical University, Oczki 3, 02-007, Warsaw, Poland

    Sławomir Lewicki & Robert Zdanowski

Authors
  1. Barbara J. Bałan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrzej K. Siwicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Krzysztof Pastewka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Urszula Demkow
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Piotr Skopiński
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ewa Skopińska-Różewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sławomir Lewicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Robert Zdanowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara J. Bałan .

Editor information

Editors and Affiliations

  1. Opole Medical School, Opole, Poland

    Mieczyslaw Pokorski

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bałan, B.J. et al. (2017). Synergistic Activity for Natural and Synthetic Inhibitors of Angiogenesis Induced by Murine Sarcoma L-1 and Human Kidney Cancer Cells. In: Pokorski, M. (eds) Clinical Research and Practice. Advances in Experimental Medicine and Biology(), vol 1020. Springer, Cham. https://doi.org/10.1007/5584_2017_17

Download citation

Publish with us

Policies and ethics

Search

Navigation